3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
76
Neoplasm Metastasis
12
Neoplasms
8
Ovarian Neoplasms
6
Endometrial Neoplasms
6
Pancreatic Neoplasms
5
Carcinoma, Renal Cell
5
Sarcoma
4
Neoplasms by Site
4
Lymphoma, Non-Hodgkin
4
Breast Diseases
4
Squamous Cell Carcinoma of Head and Neck
3
Multiple Myeloma
3
Lymphoma
3
Lung Neoplasms
3
Liposarcoma
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Glioma
3
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Interventions
Specimen Handling
7
Biopsy
6
Cyclophosphamide
5
ruxolitinib
4
Mycophenolic Acid
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Tacrolimus
3
Melphalan
3
Injections
3
Decitabine
3
Cyclosporine
3
Azacitidine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
onvansertib
1
merphos
1
iadademstat
1
gilteritinib
1
fedratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
palbociclib
×
1 year
×
Clear all
No trials found.